Loading ...

Lauren Higdon, PhD

Immune Tolerance Network

Director, Biomarker Discovery Research

Assessment Group

lhigdon@immunetolerance.org

Work: 

Mobile: 

Address: 

Immune Tolerance Network

Committees: 

, 

Studies: 

ITN066AI

-

Type 1 Diabetes Extension Study

ITN095AI

-

Siplizumab in T1DM

ITN832AI

-

Clinical phase II/III trial of Ustekinumab to treat type 1 diabetes.

Bio:

Admin Links

Shortcuts

ITN Documents

Links

A clinical research consortium sponsored by NIAID

Home

|

News

|

Members

|

Library

|

IT Support
© Immune Tolerance Network